Reumatoloxía
Servicio
University of Alabama at Birmingham
Birmingham, Estados UnidosPublicacións en colaboración con investigadores/as de University of Alabama at Birmingham (14)
2024
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Seminars in Arthritis and Rheumatism, Vol. 65
-
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments
Seminars in Arthritis and Rheumatism, Vol. 65
2023
-
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance
Arthritis Care and Research, Vol. 75, Núm. 1, pp. 53-60
-
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: Results from the open-label, randomised controlled ORAL Surveillance trial
Annals of the Rheumatic Diseases, Vol. 82, Núm. 3, pp. 331-343
2022
-
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978
-
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies
RMD open, Vol. 8, Núm. 1
2021
-
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 3, pp. 593-600
2018
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
Clinical Microbiology and Infection, Vol. 24, pp. S10-S20
2017
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977
-
Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studies
Annals of the Rheumatic Diseases, Vol. 76, Núm. 11, pp. 1870-1882
2016
-
A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis
Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111
2015
-
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 963-969
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196